The funds will facilitate the clinical progression of ABO-101, the company’s lead therapeutic candidate targeting PH1.

Shortly after this publication, Bogdanove struck up a collaboration with Daniel Voytas, a plant geneticist at the University ...

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

Advancements in genome editing, particularly CRISPR, are reshaping precision biology, driving innovations in medicine, agriculture, and synthetic biology.

Researchers are using gene editing techniques to introduce beneficial traits like polled and disease resistance, as well as ...

The growing occurrence of genetic disorders like sickle cell anemia, cystic fibrosis, and muscular dystrophy is fueling the demand for gene therapy and genome editing solutions, as these approaches ...

Explore the Genome Editing Market size, share, trends, and future growth. Learn about CRISPR, TALENs, ZFNs, and advancements shaping genetic research & medicine.

Analysts have set 12-month price targets for Precision BioSciences, revealing an average target of $53.5, a high estimate of $60.00, and a low estimate of $34.00. Staying constant with the previous ...

Researchers at Duke University and North Carolina State University have discovered a handful of new CRISPR-Cas systems that ...

Caribou Biosciences (CRBU) reported better-than-expected earnings in the first quarter, with top and bottom-line beats.